PIPERACILLIN/TAZOB. Fresenius i.v. 4.5 g flac

7680630010032 CH-63001 J01CR05 08.01.93
PIPERACILLIN/TAZOB. Fresenius i.v. 4.5 g flac
PIPERACILLIN/TAZOB. Fresenius i.v. 4.5 g flac
PIPERACILLIN/TAZOB. Fresenius i.v. 4.5 g flac
1 / 3
google

Details

Product number
6300102
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Praeparatio cryodesiccata: piperacillinum 4 g ut piperacillinum natricum, tazobactamum 500 mg ut tazobactamum natricum, pro vitro.

Articles (1)

Piperacillin/Tazobactam Fresenius i.v. 4 g/0.5 g, Pulver zur Herstellung einer Infusionslösung
Pulver
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
30/07/2025
Professional SmPC
Français
30/07/2025
Professional SmPC
Italien
30/07/2025

Detailed composition

Substance Quantity Type Category
PRC
4.0 G Substance Wirkstoff (Principe actif)
PRC
4.17 G Substance WIZUS
PRC
500.0 MG Substance Wirkstoff (Principe actif)
PRC
536.6 MG Substance WIZUS
PRC
224.0 MG Substance HBESI

Reimbursement information

Public price
CHF 37.55
Specialties list
Yes
Generic
Yes
SL addition date: 01/02/2014

Authorization holder

Fresenius Kabi (Schweiz) AG

6010 Kriens

Authorization information

Swissmedic authorization number
63001
Drug name
Piperacillin/Tazobactam Fresenius i.v., Pulver zur Herstellung einer Infusionslösung
Galenic form
PULVI
ATC Code
J01CR05
Authorization status
Z
Dispensation category
A
First authorization
05/12/2013
Authorization expiration date
31/12/9999
IT number
08.01.93
Domain
Human medicine
Field of application
Infektionskrankheiten

Packaging details

Description (FR)
PIPERACILLIN/TAZOB. Fresenius i.v. 4.5 g flac
Description (DE)
PIPERACILLIN/TAZOB. Fresenius i.v. 4.5 g Durchstf
Market launch
05/12/2013
Narcotic (BTM)
No

Other packaging sizes

PIPERACILLIN/TAZOB. Fresenius i.v. 2.25 g flac
1 DUR
View
PIPERACILLIN/TAZOB. Fresenius i.v. 4.5 g 10 pce
10 DUR
View